SharpLink
- Market cap
- 1.94B
- P/E (TTM)i
- -1.99
- P/Bi
- 1.38
- EPSi
- -7.37
- Div yieldi
- 0.00%
- 52W posi
- 38%
Anonymous reader poll. Unscientific, not investment advice.
Valuation each multiple against its own 5-year range
Vs. peers Capital Markets
| Company | Market cap | P/E (TTM)i | P/Bi | Div yieldi |
|---|---|---|---|---|
| SharpLink (SBET) | 1.94B | -1.99 | 1.38 | 0.00% |
| Morgan Stanley (MS) | 297.95B | 15.32 | 2.80 | 2.11% |
| Goldman Sachs (GS) | 258.33B | 13.70 | 2.35 | 1.92% |
| Charles Schwab (SCHW) | 165.29B | 17.41 | 3.76 | 1.23% |
| Robinhood (HOOD) | 98.46B | 48.46 | 10.39 | 0.00% |
| Interactive Brokers (IBKR) | 39.75B | 34.82 | 6.73 | 0.37% |
Other StockVane-tracked companies in the same industry.
Morningstar
Trading 1.8% below Morningstar's fair value estimate.
Fair value
Sharplink Inc earns a 3-star quantitative star rating, illustrating our stance that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a 5% premium over our quantitative fair value estimate of $9.11 per share; however, this estimate should be taken with a pinch of salt due to its very high uncertainty rating.
The firm's lack of profitability weakens our fair value estimate. Companies with low profitability are often less resilient in recessions and are likely to generate weaker future cash flows for shareholders. Reflecting the firm's profitability is its sales yield of 2.7%, which ranks in the bottom 10% compared with global peers. This company's inability to generate significant sales growth without meaningful capital investment is a challenge, which contributes to our view that shares are overvalued.
The firm's valuation metrics are an additional cause for concern. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. The firm's enterprise value to EBITDA ratio of 128.0, a core component of valuation, sits in the top 10% compared with peers globally. This suggests that the value of its enterprise value, or the value of its shares and debt, is a high multiple of the generated EBITDA. This characteristic further promotes our unfavorable price/fair value ratio.
Economic moat
This company lacks a competitive advantage, receiving a quantitative economic moat rating of none. Additionally, the firm's moderate financial health score suggests it is acceptably positioned against adverse economic circumstances.
By Quantitative Equity Report
Quote time 2026-10-08 07:40:19 · For reference only, not investment advice and not tailored to your situation.